Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,971 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,884 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01931943 | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer | unknown | Phase 1 | 24 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 30, 2013 | clinicaltrials |
| NCT01930630 | ESI With EUS to Differentiate T3 and T4 ESCC(ESI) | unknown | Phase 1 | 10 | Sun Yat-sen UniversityOTHER | 1 | Aug 29, 2013 | clinicaltrials |
| NCT00562068 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | unknown | Phase 1 | 30 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00946543 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | unknown | Phase 1 | 198 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01082198 | Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes | unknown | Phase 1 / Phase 2 | 22 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01124682 | 3-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder | unknown | Phase 1 | 60 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01460888 | Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus(ROCOCO) | unknown | Phase 1 | 36 | The Christie NHS Foundation TrustOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00931450 | Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 1 / Phase 2 | 70 | Institut Català d'OncologiaOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00003920 | Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | 18 | University of California, DavisOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00005992 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00008021 | Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00020644 | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer | unknown | Phase 1 | — | Advocate Lutheran General HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00021268 | Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | unknown | Phase 1 | 35 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00886717 | Paclitaxel-Loaded Polymeric Micelle and Carboplatin as First-Line Therapy in Treating Patients With Advanced Ovarian Cancer | unknown | Phase 1 / Phase 2 | 74 | Asan Medical CenterOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT01728389 | Intrabone Transplantation of Allogenic Peripheral Blood Stem Cells in Patients With Myeloid and Lymphoid Malignancies. | unknown | Phase 1 / Phase 2 | 10 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Jul 24, 2013 | clinicaltrials |
| NCT01304745 | Rehabilitation of Women Following Treatment for Gynaecological Cancer; a Randomized, Controlled Study | unknown | Phase 1 | 130 | Haukeland University HospitalOTHER | 1 | Jul 9, 2013 | clinicaltrials |
| NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer(Beva) | unknown | Phase 1 | 30 | Association Tunisienne de lutte Contre le CancerOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01880411 | Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine | unknown | Phase 1 | 15 | HealthBanks Biotech Co., Ltd.INDUSTRY | 0 | Jun 19, 2013 | clinicaltrials |
| NCT01695590 | Safety, Efficacy and Pharmacokinetic Study of PRLX 93936 in Patients With Multiple Myeloma | unknown | Phase 1 / Phase 2 | 40 | Prolexys PharmaceuticalsINDUSTRY | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00004173 | Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer | unknown | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00009932 | Combination Chemotherapy in Treating Patients With Solid Tumors | unknown | Phase 1 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT01147211 | Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC) | unknown | Phase 1 | 21 | National Taiwan University HospitalOTHER | 1 | May 3, 2013 | clinicaltrials |
| NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | unknown | Phase 1 / Phase 2 | 40 | Fudan UniversityOTHER | 1 | Apr 30, 2013 | clinicaltrials |
| NCT00930566 | Extracorporal Photopheresis Pilot Study(ECP) | unknown | Phase 1 / Phase 2 | 20 | Hospices Civils de LyonOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01192087 | Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT) | unknown | Phase 1 / Phase 2 | 49 | Heidelberg UniversityOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT01828918 | Biomarkers for the Early Diagnosis, Prediction, Prognosis for Colorectal Cancers | unknown | Phase 1 | 300 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Apr 11, 2013 | clinicaltrials |
| NCT01686386 | Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma | unknown | Phase 1 / Phase 2 | 60 | Gruppo Italiano Studio LinfomiOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00639925 | Antiangiogenic Peptide Vaccine Therapy With Gemcitabine in Treating Patient With Pancreatic Cancer | unknown | Phase 1 | 5 | Fukushima Medical UniversityOTHER | 1 | Mar 14, 2013 | clinicaltrials |
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | unknown | Phase 1 | 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Mar 8, 2013 | clinicaltrials |
| NCT01456065 | Safety of Active Immunotherapy in Subjects With Ovarian Cancer | unknown | Phase 1 | 15 | Life Research Technologies GmbHOTHER | 2 | Mar 1, 2013 | clinicaltrials |
| NCT01387399 | Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer(HIPEC ROC I) | unknown | Phase 1 | 9 | University Hospital, BonnOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00636922 | Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia | unknown | Phase 1 | 40 | Bayside HealthOTHER_GOV | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00551122 | Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors(GemTIP) | unknown | Phase 1 / Phase 2 | 23 | University of SouthamptonOTHER | 1 | Jan 23, 2013 | clinicaltrials |
| NCT01760811 | CETUXIMAB Given for 3 Weeks as Neoadjuvant Treatment in Locally Advanced Tongue Cancer ; A NEW PARADIGM OF TREATMENT | unknown | Phase 1 / Phase 2 | 25 | Rabin Medical CenterOTHER | 1 | Jan 4, 2013 | clinicaltrials |
| NCT01226407 | Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile | unknown | Phase 1 | 36 | CrystalGenomics, Inc.INDUSTRY | 1 | Dec 31, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01716364 | Safety Study of Anti LewisY Chimeric Antigen Receptor in Myeloma, Acute Myeloid Leukemia or Myelodysplastic Syndrome | unknown | Phase 1 | 6 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01739634 | The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer | unknown | Phase 1 / Phase 2 | 10 | Salient Pharmaceuticals IncorporatedINDUSTRY | 1 | Dec 3, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01724944 | LYmphadenectomy After NeoAdjuvant Chemotherapy(LYANA) | unknown | Phase 1 / Phase 2 | 65 | Catholic University of the Sacred HeartOTHER | 1 | Nov 12, 2012 | clinicaltrials |
| NCT01724320 | A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors | unknown | Phase 1 | 20 | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)INDUSTRY | 2 | Nov 9, 2012 | clinicaltrials |
| NCT01331915 | Safety and Toxicity Study of Vaccination for Advanced Metastatic Melanoma Patients(THERAVAC) | unknown | Phase 1 / Phase 2 | 23 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 10, 2012 | clinicaltrials |
| NCT01697891 | A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers | unknown | Phase 1 / Phase 2 | 35 | McMaster UniversityOTHER | 1 | Oct 2, 2012 | clinicaltrials |
| NCT01037556 | PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia | unknown | Phase 1 / Phase 2 | 50 | Proacta, IncorporatedINDUSTRY | 1 | Aug 31, 2012 | clinicaltrials |
| NCT00397800 | Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 12 | Technical University of MunichOTHER | 1 | Aug 28, 2012 | clinicaltrials |
| NCT01315431 | A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors | unknown | Phase 1 | 9 | Genta IncorporatedINDUSTRY | 1 | Jul 24, 2012 | clinicaltrials |
| NCT00838240 | Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia(AML-14A) | unknown | Phase 1 / Phase 2 | 114 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 20, 2012 | clinicaltrials |
| NCT00396617 | Voice Prosthesis Made in Porous Titanium After Total Laryngectomy or Pharyngolaryngectomy | unknown | Phase 1 | 14 | University Hospital, Strasbourg, FranceOTHER | 1 | Jul 2, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Aug 30, 2013source: clinicaltrials